These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 18416543)
21. Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors. Ganesan R; Jelakovic S; Campbell AJ; Li ZZ; Asgian JL; Powers JC; Grütter MG Biochemistry; 2006 Aug; 45(30):9059-67. PubMed ID: 16866351 [TBL] [Abstract][Full Text] [Related]
22. Activity-based probes that target diverse cysteine protease families. Kato D; Boatright KM; Berger AB; Nazif T; Blum G; Ryan C; Chehade KA; Salvesen GS; Bogyo M Nat Chem Biol; 2005 Jun; 1(1):33-8. PubMed ID: 16407991 [TBL] [Abstract][Full Text] [Related]
23. Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain. González FV; Izquierdo J; Rodríguez S; McKerrow JH; Hansell E Bioorg Med Chem Lett; 2007 Dec; 17(24):6697-700. PubMed ID: 17977725 [TBL] [Abstract][Full Text] [Related]
24. Substrate specificity of schistosome versus human legumain determined by P1-P3 peptide libraries. Mathieu MA; Bogyo M; Caffrey CR; Choe Y; Lee J; Chapman H; Sajid M; Craik CS; McKerrow JH Mol Biochem Parasitol; 2002 Apr; 121(1):99-105. PubMed ID: 11985866 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain. Lee J; Bogyo M Bioorg Med Chem Lett; 2012 Feb; 22(3):1340-3. PubMed ID: 22243962 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant. Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485 [TBL] [Abstract][Full Text] [Related]
27. An enormously active and selective azapeptide inhibitor of cathepsin B. Wieczerzak E; Rodziewicz-Motowidło S; Jankowska E; Giełdoń A; Ciarkowski J J Pept Sci; 2007 Aug; 13(8):536-43. PubMed ID: 17617796 [TBL] [Abstract][Full Text] [Related]
36. The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter. Lowe JA; Hou X; Schmidt C; David Tingley F; McHardy S; Kalman M; Deninno S; Sanner M; Ward K; Lebel L; Tunucci D; Valentine J; Bronk BS; Schaeffer E Bioorg Med Chem Lett; 2009 Jun; 19(11):2974-6. PubMed ID: 19410451 [TBL] [Abstract][Full Text] [Related]
37. Studies on aromatic compounds: inhibition of calpain I by biphenyl derivatives and peptide-biphenyl hybrids. Montero A; Alonso M; Benito E; Chana A; Mann E; Navas JM; Herradón B Bioorg Med Chem Lett; 2004 Jun; 14(11):2753-7. PubMed ID: 15125927 [TBL] [Abstract][Full Text] [Related]
38. Stereocontrolled synthesis of psi[CH(CF3)NH]gly-peptides. Molteni M; Volonterio A; Zanda M Org Lett; 2003 Oct; 5(21):3887-90. PubMed ID: 14535735 [TBL] [Abstract][Full Text] [Related]
39. Relative rates of Michael reactions of 2'-(phenethyl)thiol with vinyl sulfones, vinyl sulfonate esters, and vinyl sulfonamides relevant to vinyl sulfonyl cysteine protease inhibitors. Reddick JJ; Cheng J; Roush WR Org Lett; 2003 May; 5(11):1967-70. PubMed ID: 12762698 [TBL] [Abstract][Full Text] [Related]
40. Solid-phase synthesis of azidomethylene inhibitors targeting cysteine proteases. Yang PY; Wu H; Lee MY; Xu A; Srinivasan R; Yao SQ Org Lett; 2008 May; 10(10):1881-4. PubMed ID: 18407644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]